Skip to main content

Table 5 Prior exposure to clinical trials and willingness to participate

From: Unique perception of clinical trials by Korean cancer patients

Question

Answers

Patients in previous clinical trials (N=127) (%)

Patients never in clinical trial (N=548) (%)

p-value

Most influential factor for clinical trial participation

Using a new drug

39(30.7)

103(18.8)

0.001

Economic benefit

8(6.3)

42(7.7)

 

Contribute to medical development

21(16.5)

98(17.9)

Physician’s recommendation

37(29.1)

144(26.3)

No other treatment option

19(15.0)

159(29.0)

Other

3(2.4)

2(0.4)

Most influential factor for refusal to participate

Negative perception of clinical trials

28(22.0)

165(30.1)

0.019

Unconfirmed treatment

65(51.2)

255(46.5)

 

Frequent hospital visits

8(6.3)

45(8.2)

Prefers standard treatment

21(16.5)

80(14.6)

Other reasons

5(4.9)

3(0.6)